Ramipril
Back to searchMolecule Structure
Scientific Name
Ramipril
Description of the Drug
Ramipril is an ACE inhibitor used for the management of hypertension and the reduction of cardiovascular mortality following myocardial infarction in hemodynamically stable patients with clinical signs of congestive heart failure.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00178
http://www.drugbank.ca/drugs/DB00178
Brand Name(s)
Altace, Lopace, Ramipril, Ranace, Tritace
Company Owner(s)
Apotex Inc, Cipla Ltd, King Pharmaceuticals Llc, Watson Laboratories Inc, Chartwell Rx Sciences Llc, Actavis Elizabeth Llc, Aurobindo Pharma Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd, Accord Healthcare Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Angiotensin-converting enzyme | SINGLE PROTEIN | INHIBITOR | CHEMBL1808 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL16059 | |
| PharmGKB | PA451223 | |
| Human Metabolome Database | HMDB0014324 | |
| DrugBank | DB00178 | |
| PubChem: Thomson Pharma | 14929182 | 14904601 |
| PubChem | 6992028 | 5362129 |
| Mcule | MCULE-5386328912 | |
| LINCS | LSM-5950 | |
| Nikkaji | J22.246A | |
| BindingDB | 50084681 | |
| EPA CompTox Dashboard | DTXSID8023551 | |
| DrugCentral | 2356 | |
| Brenda | 159770 | |
| ChemicalBook | CB0249104 | |
| Guide to Pharmacology | 6339 | |
| rxnorm | ALTACE | RAMIPRIL |
| PubChem: Drugs of the Future | 12012944 | |
| ChEBI | 8774 | |
| ZINC | ZINC000003798757 |
